Resumen

TEJEDOR-TEJADA, E  y  FERNANDEZ-FREIRE, A. Cemiplimab effectiveness in squamous cell cancer, a case report. Rev. OFIL·ILAPHAR [online]. 2023, vol.33, n.2, pp.212-213.  Epub 04-Mar-2024. ISSN 1699-714X.  https://dx.doi.org/10.4321/s1699-714x2023000200017.

Cemiplimab has shown substantial anntitumor activity in patients with cutaeous squamous cell carcinoma. Patients with locally advanced cutaneous squamous cell carcinoma have a por prognosis with conventional systemic therapy. We present a case report of the safety and antitumor activity of cemiplimab in a patient with locally advanced cutaneous squamous cell carcinoma.

Palabras clave : Immunotherapy; anti-PDL1; oncology.

        · resumen en Español     · texto en Español     · Español ( pdf )